A digital health intervention that allows patients to self-order tests can increase colorectal cancer screening, a recent study found. The randomized controlled trial examined the effect of a digital health intervention, Mobile Patient Technology for Health-CRC (mPATH-CRC), on rates of CRC screening. 450 patients (223 in the mPATH-CRC group and 227 in usual care) from 6 community-based primary care practices who were scheduled for a primary care visit and due for routine CRC screening were included. The iPad application displays a CRC screening decision aid, lets patients order their own screening tests, and sends automated follow-up electronic messages to support patients. The primary outcome was chart-verified completion of CRC screening within 24 weeks. Researchers found:
- Baseline characteristics were similar between groups.
- Screening was completed by 30% of the mPATH-CRC participants vs 15% in the usual care group.
- Compared with usual care, more mPATH-CRC participants could state a screening preference, planned to be screened within 6 months, discussed screening with their provider, and had a screening test ordered.
- Approximately half of mPATH-CRC users “self-ordered” a test.
Miller DP, Denizard-Thompson N, Weaver KE, et al. Effect of a digital health intervention on receipt of colorectal cancer screening in vulnerable patients: A randomized controlled trial. [Published online ahead of print March 13, 2018]. Ann Intern Med. doi:10.7326/M17-2315.
This Week's Must Reads
Must Reads in Oncology
Consumption of SSBs & Risk of Mortality, Circulation; ePub 2019 Mar 18; Malik, et al
Ultrasonography Screening in Breast Cancer, JAMA Intern Med; ePub 2019 Mar 18; Lee, et al
Do Vitamin D Supplements Prevent Cancer, CVD?, N Engl J Med; 2019 Jan 3; Manson, Cook, et al
Nonadherence to Cancer Screenings & Related Mortality, JAMA Intern Med; ePub 2018 Dec 28; Pierre-Victor, et al
Does Vitamin D Reduce Cancer & CVD Risk?, N Engl J Med; ePub 2018 Nov 10; Manson, et al